+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cancer Immunotherapy"

From
From
Oncolytic Virus Therapy - Global Strategic Business Report - Product Thumbnail Image

Oncolytic Virus Therapy - Global Strategic Business Report

  • Report
  • November 2026
  • 483 Pages
  • Global
From
Stomach Cancer Treatment - Global Strategic Business Report 2026 - Product Thumbnail Image

Stomach Cancer Treatment - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 371 Pages
  • Global
From
Injectable Cytotoxic Drugs - Global Strategic Business Report 2026 - Product Thumbnail Image

Injectable Cytotoxic Drugs - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 380 Pages
  • Global
From
Cellular Immunotherapy - Global Strategic Business Report 2026 - Product Thumbnail Image

Cellular Immunotherapy - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 386 Pages
  • Global
From
From
Cancer Biological Therapy - Global Strategic Business Report 2026 - Product Thumbnail Image

Cancer Biological Therapy - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 211 Pages
  • Global
From
Antibody Drug Conjugates (ADC) - Global Strategic Business Report - Product Thumbnail Image

Antibody Drug Conjugates (ADC) - Global Strategic Business Report

  • Report
  • November 2026
  • 193 Pages
  • Global
From
From
From
Urothelial Cancer Drugs - Global Strategic Business Report 2026 - Product Thumbnail Image

Urothelial Cancer Drugs - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 126 Pages
  • Global
From
From
Interferon - Global Strategic Business Report 2026 - Product Thumbnail Image

Interferon - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 153 Pages
  • Global
From
Immunotherapy Drugs - Global Strategic Business Report 2026 - Product Thumbnail Image

Immunotherapy Drugs - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 233 Pages
  • Global
From
Cancer Therapies - Global Strategic Business Report - Product Thumbnail Image

Cancer Therapies - Global Strategic Business Report

  • Report
  • November 2026
  • 590 Pages
  • Global
From
Immuno Oncology Assays Market Global Report 2026 - Product Thumbnail Image

Immuno Oncology Assays Market Global Report 2026

  • Report
  • October 2026
  • 250 Pages
  • Global
From
From
Bispecific Antibody Cancer Therapy Market Global Report 2026 - Product Thumbnail Image

Bispecific Antibody Cancer Therapy Market Global Report 2026

  • Report
  • April 2026
  • 250 Pages
  • Global
From
Interleukin-2 (IL-2) Mutein Therapies Market Report 2026 - Product Thumbnail Image

Interleukin-2 (IL-2) Mutein Therapies Market Report 2026

  • Report
  • March 2026
  • 250 Pages
  • Global
From
Loading Indicator

Cancer Immunotherapy is a type of Immune Disorders Drugs that uses the body's own immune system to fight cancer. It works by stimulating the body's natural defense system to recognize and attack cancer cells. This type of therapy is used to treat a variety of cancers, including melanoma, lymphoma, and leukemia. It can also be used to treat other types of cancer, such as breast, lung, and colorectal cancer. Cancer Immunotherapy is a rapidly growing field, with many new treatments being developed. It is an important part of the overall cancer treatment landscape, as it can provide a more targeted approach to treating cancer. It can also be used in combination with other treatments, such as chemotherapy and radiation therapy, to improve outcomes. Some of the companies in the Cancer Immunotherapy market include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Roche. These companies are developing a range of treatments, including monoclonal antibodies, vaccines, and cell-based therapies. Show Less Read more